Abstract
In March 2020, individuals shielding from coronavirus reported high rates of distress. This study investigated whether fear of contamination (FoC) and use of government-recommended behaviours (GRB; e.g., handwashing and wearing masks) were associated with psychological distress during February 2021. An online cross-sectional questionnaire assessed psychological distress in three groups (shielding self, shielding other/s, and control), and those shielding others also completed an adapted measure of health anxiety (α = 0.94). The sample (N = 723) was predominantly female (84%) with a mean age of 41.72 (SD = 15.15). Those shielding (self) demonstrated significantly higher rates of health anxiety and FoC in comparison to other groups (p < 0.001). The use of GRB was significantly lower in controls (p < 0.001), with no significant difference between the two shielding groups (p = 0.753). Rates of anxiety were higher when compared to March 2020 findings, except for controls. Hierarchical regressions indicated FoC and GRB accounted for 24% of variance in generalised anxiety (p < 0.001) and 28% in health anxiety, however, the latter was a non-significant predictor in final models. Those shielding themselves and others during the pandemic have experienced sustained levels of distress; special consideration must be given to those indirectly affected. Psychological interventions should account for realistic FoC and the impact of government-recommended health behaviours, as these factors are associated with distress in vulnerable groups and may extend beyond the pandemic. Future research should focus on longitudinal designs to monitor and better understand the clinical needs of those shielding, and those shielding others post-pandemic.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference88 articles.
1. Coronavirus Disease (COVID-19)
https://www.who.int/health-topics/coronavirus#tab=tab_3
2. Veklury
https://www.ema.europa.eu/en/medicines/human/EPAR/veklury
3. First COVID-19 Treatment to Be Made Available for Use in UK Outside a Clinical Trial
https://pharmaceutical-journal.com/article/news/first-covid-19-treatment-to-be-made-available-for-use-in-uk-outside-a-clinical-trial
4. Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech (Regulation 174);Medicines & Healthcare Products Regulatory Agency
5. A global database of COVID-19 vaccinations
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献